Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human PODXL Protein, N-His

Catalog #:   YHA16801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O00592
Protein length: Ser23-Leu428
Overview

Catalog No.

YHA16801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser23-Leu428

Predicted molecular weight

43.92 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O00592

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

PCLP1, Podocalyxin-like protein 1, GCTM-2 antigen, Gp200, PODXL, Podocalyxin, PC, PCLP, PCLP-1

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human PODXL protein
References

Stromal Cell-Derived Factor-1, P-Selectin, and Advanced Oxidation Protein Products with Mitochondrial Dysfunction Concurrently Impact Cerebral Vessels in Patients with Normoalbuminuric Diabetic Kidney Disease and Type 2 Diabetes Mellitus., PMID:40429625

Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy., PMID:40407599

Whole genome sequencing identifies monogenic disease in 56.1% of families with early-onset steroid-resistant nephrotic syndrome., PMID:40402239

Renal Implications of Psoriasis: Urinary Podocyte Markers and Disease Progression., PMID:40401891

Asperosaponin VI Promotes Osteoporotic Fracture Healing by Targeting Piezo1 to Enhance the Coupling of LEPR+ BMSCs and PODXL+ ECs., PMID:40393465

Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes., PMID:40287221

Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies., PMID:40282423

Yishen Tongluo formula ameliorates kidney injury modulating inflammation and apoptosis in streptozotocin-induced diabetic kidney disease mice., PMID:40151112

Podocyte-Specific Protein Expression in Urine Exosome Acts as a Marker for Renal Injury in Post-COVID State., PMID:40100769

Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin., PMID:39867135

Mechanism Study on the Regulation of Th1/Th2 in the Treatment of Idiopathic Membranous Nephropathy by Shengyang Yiwei Decoction., PMID:39812058

Anti-Adhesive Podocalyxin Expression Is Disrupted in Recurrent Implantation Failure., PMID:39795629

APOL1 Modulates Renin-Angiotensin System., PMID:39766282

Investigation of clinical and subclinical renal damage in Psoriasis., PMID:39666126

Development of a Multiplexed LC-MS/MS Assay for the Quantitation of Podocyte Injury Biomarkers Nephrin, Podocalyxin, and Podocin in Human Urine., PMID:39651829

Receptive window might be shorter in patients with endometriosis and lesions cyclically prepare for implantation., PMID:39643002

Isoferulic acid regulates CXCL12/CXCR4-mediated apoptosis and autophagy in podocyte and mice with STZ-induced diabetic nephropathy., PMID:39616856

Comparative proteomic exploration of plasma proteins in different levels of vitamin D with type 2 diabetes mellitus using iTRAQ-coupled LC-MS/MS., PMID:39610489

Towards the Identification of New Biomarkers in Saliva and Serum for Treatment Monitoring of Equine Gastric Ulcer Syndrome: A Liquid Proteomic Approach., PMID:39518828

Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance., PMID:39507251

Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma., PMID:39448867

Polycystic Ovary Syndrome Accompanied by Hyperandrogenemia or Metabolic Syndrome Triggers Glomerular Podocyte Injury., PMID:39410601

Single-cell RNA transcriptomics reveals Du-Zhong-Wan promotes osteoporotic fracture healing via YAP/β-catenin/VEGF axis in BMSCs., PMID:39366157

Adriamycin-induced podocyte injury via the Sema3A/TRPC5/Rac1 pathway., PMID:39301490

Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapy., PMID:39294825

PPAR-α Insufficiency Enhances Doxorubicin-Induced Nephropathy in PPAR-α Knockout Mice and a Murine Podocyte Cell Line., PMID:39273018

Has_circ_0002360 promotes the progression of lung adenocarcinoma by activating miR-762 and regulating PODXL expression., PMID:39262484

PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway., PMID:39198365

CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression., PMID:39186674

Non-endothelial expression of endomucin in the mouse and human choroid., PMID:39153592

6-Gingerol modulates miRNAs and PODXL gene expression via methyltransferase enzymes in NB4 cells: an in silico and in vitro study., PMID:39112503

The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte., PMID:39074452

Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma., PMID:39051568

Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C., PMID:38983807

EGR3 reduces podocyte inflammatory damage in obesity related glomerulopathy by inhibiting the PRMT1/p-STAT3 pathway., PMID:38970508

Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases-A Cross-Sectional Study., PMID:38929959

Catechin-Induced changes in PODXL, DNMTs, and miRNA expression in Nalm6 cells: an integrated in silico and in vitro approach., PMID:38879474

Interferon-γ induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease., PMID:38838223

Non-endothelial expression of Endomucin in the mouse and human choroid., PMID:38559191

Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma., PMID:38553472

Redistribution of the glycocalyx exposes phagocytic determinants on apoptotic cells., PMID:38359833

Urinary podocyte markers in diabetic kidney disease., PMID:38325865

Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles., PMID:38321535

A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts., PMID:38203331

Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier., PMID:37932749

AT7867 promotes pancreatic progenitor differentiation of human iPSCs., PMID:37922913

Effects and mechanism of Rictor interference in podocyte injury induced by high glucose., PMID:37753299

Repurposing fexofenadine as a promising candidate for diabetic kidney disease: randomized clinical trial., PMID:37741921

Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy., PMID:37675364

Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway., PMID:37640899

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human PODXL Protein, N-His [YHA16801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only